Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study on myasthenia gravis (MG) just published in the journal Neurology. MG… read more
Author Archives: cmccormick
HEORStrategies’ Dr. Naomi Sacks is a co-author on a large-scale study of obesity and overweight in the United States
Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study just published in the journal Obesity Science and Practice. Using national… read more
Announcing HEORStrategies, the newest division of ToxStrategies LLC!
HEORStrategies provides robust, strategic health economics and outcomes research (HEOR) consulting services to pharma, biotech, and medical device clients!
EpidStrategies’ Scientists are Presenting on RSV at IDWeek 2023
EpidStrategies’ scientists are recognized experts in the field of respiratory syncytial virus (RSV). Our RSV research program supported the newly-approved monoclonal antibody with… read more
Dr. Michael Kelsh joins EpidStrategies, a Division of ToxStrategies LLC
New Infant RSV Prevention to be Available this Fall
ToxStrategies Acquires Modality Solutions
EpidStrategies scientists present at ICPE 2023, Halifax Nova Scotia, August 23-27
EpidStrategies’ Scientists Support ASPN Award-Winning Abstract
Congratulations to our colleagues at NeuraLace Medical for receiving the Best Abstract Award from the American Society of Pain & Neuroscience (ASPN) 2023 conference for their Axon Therapy magnetic Peripheral Nerve Stimulation device, developed to treat chronic neuropathic pain. Analytical support was provided by EpidStrategies’ scientists Heidi Reichert, Gina Nicholson, Josie Gauthier, and Xiaohui Jiang. We are happy to provide support for such innovative science.
